Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-EBV/HHV-4 LMP1/BNLF1 Antibody (F5)

Catalog #:   RVV07009 Specific References (94) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA, IP
Accession: P03230
Overview

Catalog No.

RVV07009

Species reactivity

Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

Latent membrane protein 1, LMP-1, Protein p63, Protein p25, LMP1, BNLF1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P03230

Applications

ELISA, IP

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

F5

Data Image
  • SDS-PAGE
    SDS PAGE for EBV/HHV-4 LMP1/BNLF1 Antibody (F5)
References

F5-peptide enhances the efficacy of the non-hormonal male contraceptive adjudin. PMID: 30763581

Identification of F5 as a Prognostic Biomarker in Patients with Gastric Cancer. PMID: 32190689

F5-Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV-short production. PMID: 33773040

Coagulation Factor V (F5) is an Estrogen-Responsive Gene in Breast Cancer Cells. PMID: 34826880

YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects. PMID: 32519033

Grasping objects and grasping action meanings: the dual role of monkey rostroventral premotor cortex (area F5). PMID: 9949817

DW-F5: A novel formulation against malignant melanoma from Wrightia tinctoria. PMID: 26061820

F5-peptide induces aspermatogenesis by disrupting organization of actin- and microtubule-based cytoskeletons in the testis. PMID: 27611949

Stacking S5-n and f5-n to overcome sterility in indica-japonica hybrid rice. PMID: 26704419

Genome-based classification of Acidihalobacter prosperus F5 (=DSM 105917=JCM 32255) as Acidihalobacter yilgarnensis sp. nov. PMID: 33112221

MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study. PMID: 31646966

Targeted next-generation resequencing of f5 gene identifies novel multiple variants pattern in severe hereditary factor v deficiency. PMID: 23662219

Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study. PMID: 29766637

Case Report: Novel Mutation of F5 With Maternal Uniparental Disomy Causes Severe Congenital Factor V Deficiency. PMID: 35747490

Hydroboration of Phosphaalkynes by HB(C6 F5 )2. PMID: 27377569

Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma. PMID: 30406970

Allelic polymorphism of F2, F5 and MTHFR genes in population of Ukraine. PMID: 20608153

Subcellular localization of the F5 protein to the neuronal membrane-associated cytoskeleton. PMID: 7932868

Clostridium botulinum strains producing BoNT/F4 or BoNT/F5. PMID: 24632257

Inhibition of Virulence Gene Expression in Salmonella Dublin, Escherichia coli F5 and Clostridium perfringens Associated With Neonatal Calf Diarrhea by Factors Produced by Lactic Acid Bacteria During Fermentation of Cow Milk. PMID: 35633687

HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2‑bromo‑5- (trifluoromethoxy)phenyl) thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt/β-catenin signaling pathway. PMID: 30466627

Novel compounds TAD-1822-7-F2 and F5 inhibited HeLa cells growth through the JAK/Stat signaling pathway. PMID: 29649626

Assessing the construct validity of musculoskeletal ultrasound and the rheumatoid arthritis foot disease activity index (RADAI-F5) for managing rheumatoid foot disease. PMID: 37251662

Significance of the p.Phe218Ser and p.Gly304Glu F5 Variants in Hereditary Factor V Deficiency. PMID: 34280927

The joint association between F5 gene polymorphisms and maternal smoking during pregnancy on preterm delivery. PMID: 19020903

Mechanism of substrate recognition by the novel Botulinum Neurotoxin subtype F5. PMID: 26794648

The Tris(pentafluoroethyl)silanide Anion. PMID: 27902868

Functional specialization of macaque premotor F5 subfields with respect to hand and mouth movements: A comparison of task and resting-state fMRI. PMID: 30802514

Prevalence of F5 1691G>A, F2 20210G>A, and MTHFR 677C>T polymorphisms in Bosnian women with pregnancy loss. PMID: 28488549

Expression of the T-lymphocyte activation gene, F5, by mature neurons. PMID: 1484386

Characterization of the neuroimmune protein F5: localization to the dendrites and perikarya of mature neurons and the basal aspect of choroid plexus epithelial cells. PMID: 8271310

The kinetics and mechanism of α-glucosidase inhibition by F5-SP, a novel compound derived from sericin peptides. PMID: 28045172

Pentafluoroethyl Bismuth Compounds. PMID: 27862439

Slc15a1 is involved in the transport of synthetic F5-peptide into the seminiferous epithelium in adult rat testes. PMID: 26537751

Facile Synthesis of Sequence-Defined Oligo(Dimethylsiloxane-co-Diphenylsiloxane)s. PMID: 33270333

Corticospinal mirror neurons. PMID: 24778371

A single-chain fragment variable recombinant antibody against F5 fimbria of enterotoxigenic Escherichia coli inhibits agglutination of horse red blood cells induced by F5 protein. PMID: 16215837

Expression and biochemical characterization of light chains of Botulinum neurotoxin subtypes F5 and F7. PMID: 25858313

Do monkey F5 mirror neurons show changes in firing rate during repeated observation of natural actions? PMID: 24371289

Fine mapping of f5-Du, a gene conferring wide-compatibility for pollen fertility in inter-subspecific hybrids of rice (Oryza sativa L.). PMID: 16317572

Reduction of enterotoxin induced fluid accumulation in ileal loops of neonatal calves with anti-F5 fimbriae recombinant antibody. PMID: 26521056

Photo-Facilitated Detection and Sequencing of 5-Formylcytidine RNA. PMID: 36251179

Cytostatic and Antiproliferative Activities of F5 Fraction of Crinum amabile Leaf Chloroform Extract Showed Its Potential as Cancer Chemotherapeutic Agent. PMID: 31097973

Detection of enterotoxigenic K99 (F5) and F41 from fecal sample of calves by molecular and serological methods. PMID: 32214971

Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas., PMID:39908567

EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma., PMID:39695702

Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy., PMID:39211169

A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations., PMID:38995124

Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma., PMID:38276183

Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness., PMID:38254830

CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy., PMID:38211650

LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells., PMID:38169736

Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus., PMID:38146370

Understanding the role of membrane cholesterol upon Epstein Barr virus infection in astroglial cells., PMID:37876925

Molecular detection of Epstein-Barr virus among Sudanese patients diagnosed with Hashimoto's thyroiditis., PMID:37858193

Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein-Barr Virus LMP1 Protein., PMID:37512884

Vaccination against Epstein-Barr Latent Membrane Protein 1 Protects against an Epstein-Barr Virus-Associated B Cell Model of Lymphoma., PMID:37508413

Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas., PMID:37426645

Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma., PMID:37373272

Epstein-Barr virus in breast carcinoma and in triple negative cases impact on clinical outcomes., PMID:37116366

Epstein-Barr Virus-Positive Leiomyosarcoma in Immunocompetent Patients., PMID:36951222

Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus., PMID:36782252

Association of human papillomavirus and Epstein-Barr virus with squamous cell carcinoma of upper aerodigestive tract., PMID:36683943

PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis., PMID:36326378

Incidence of Epstein-Barr Virus Among Women With Breast Cancer Using Monoclonal Antibodies for Latent Membrane Protein 1 (LMP1)., PMID:35478129

Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis., PMID:34790199

Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response., PMID:34728343

Uncovering early events in primary Epstein-Barr virus infection using a rabbit model., PMID:34707156

Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases., PMID:34691042

Plasmablastic lymphomas show restricted EBV latency profile and MYC gene aberrations., PMID:34612761

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma., PMID:34546798

Updating targets for natural killer/T-cell lymphoma immunotherapy., PMID:33628584

Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity., PMID:33613527

Selection of new immunotherapy targets for NK/T cell lymphoma., PMID:33312349

A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma., PMID:33067267

Epstein-Barr virus infection in patients with chronic gastritis without Helicobacter pylori infection., PMID:32343232

A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis., PMID:32333154

[Expression of LMP-1 protein in tumor cells and glandular epithelium of the peritumoral tissue in gastric cancer]., PMID:31851189

CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo., PMID:31807014

Construction of Epstein-Bar virus cocktail peptide fused with Fcγ of IgG: as a potential delivery system for vaccine development., PMID:31739735

Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma., PMID:31618442

Total Antioxidant Status (TAS), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) in Oropharyngeal Cancer Associated with EBV Infection., PMID:31360295

Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma., PMID:31063269

Fibronectin promotes nasopharyngeal cancer cell motility and proliferation., PMID:30551431

Epstein Barr Virus in Patients with Nephropathy Associated with Systemic Lupus Erythematous, Pilot Study in Egyptian Patients., PMID:30242993

Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1., PMID:30137504

Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas., PMID:29946193

Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma., PMID:29761078

The Relationship Between Environmental Factors and the Profile of Epstein-Barr Virus Antibodies in the Lytic and Latent Infection Periods in Healthy Populations from Endemic and Non-Endemic Nasopharyngeal Carcinoma Areas in China., PMID:29606628

The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus., PMID:29497417

Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus., PMID:29338588

The potential of currently unavailable herpes virus vaccines., PMID:29313728

Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar., PMID:29228016

Analysis of Immunogenicity of Intracellular CTAR Fragments of Epstein-Barr Virus Latent Phase Protein LMP1., PMID:29063322

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-EBV/HHV-4 LMP1/BNLF1 Antibody (F5) [RVV07009]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only